AAM taps John Murphy as president and CEO Murphy most recently served as the chief policy officer at the Biotechnology Innovation Organization. NACDS participates in White House meeting regarding respiratory illness seasonNACDS member pharmacies recently participated in a meeting with the White House Office of Pandemic Preparedness and Response Policy. AAM to Congress: Pass key bills considered by the Senate HELP Committee AAM commended the slated mark up by the Senate Health, Education, Labor and Pensions Committee of two pieces of legislation. AAM: Generic medicines increase patient access more than government negotiated price controls AAM is urging Congress and regulators to stop patent abuses and streamline approvals. Biosimilars Council urges House to pass patent thicket legislation S. 150 passed the Senate and was placed on the House of Representatives' suspension calendar. NACDS, ADA join to provide nutrition education to prevent chronic diseases The #NourishMyHealth campaign will be featured at the ADA's Tour de Cure and Step Out Walk to Stop Diabetes events. AAM, Biosimilars Council releases statement on statement on Senate Judiciary Markup of PREVAIL and PERA The Association for Accessible Medicines and its Biosimilars Council oppose passage of the PREVAIL Act and the PERA Act. Former FDA commissioner Scott Gottlieb will keynote AAM's annual meeting Scott Gottlieb also will moderate the CEOs Unplugged session, where healthcare executives will share their candid insights and industry perspectives. AAM, Biosimilar Council host patent abuse Congressional briefing AAM, The ERISA Industry Committee and Transparency-Rx sent a letter to Congressional leaders urging prompt legislative action. Former FDA commissioner Janet Woodcock to headline AAM’s GRx+Biosims conference The conference takes place in Rockland, Md., Oct. 21-23. First Previous 6 7 8 9 10 Next Last
